Back to Browse Journals » Clinical Audit » Volume 5

Medication adherence issues in patients: focus on cost

Authors Matsui D

Published Date March 2013 Volume 2013:5 Pages 33—42

DOI http://dx.doi.org/10.2147/CA.S30125

Received 9 November 2012, Accepted 11 January 2013, Published 9 March 2013

Doreen Matsui

Department of Pediatrics and Medicine, University of Western Ontario, London, Ontario, Canada; Children's Hospital, London Health Sciences Centre, London, Ontario, Canada; Children's Health Research Institute, London, Ontario, Canada

Abstract: Advances in drug therapy have resulted in efficacious treatments being available; however, the benefit may be lost if prescribed medications are not taken properly. Unfortunately, poor medication adherence is common and widespread, affecting all age groups and disease conditions. Adherence is a factor in health outcomes of pharmacotherapy with possible failure to achieve therapeutic goals and worsening of illness. Higher health care costs may result from more frequent physician and emergency department visits and increased hospitalization rates. The cost of medications may play a role in whether patients do or do not take their medication with increased cost sharing leading to poorer adherence with prescription drugs. Given the possible adverse consequences of nonadherence, interventions to improve medication-taking behavior are encouraged although not consistently successful. Surprisingly, there is relatively little information on the cost-effectiveness of these interventions and more methodologically sound research is needed in this area. Alternative strategies that have been proposed are value-based insurance design and the use of financial incentives, although the former has not been widely accepted, and the latter is ethically controversial. This article reviews some of the main issues with regards to adherence with drug therapy including some of the cost implications of less than optimal medication adherence.

Keywords: adherence, medication, cost

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Visual fields in a chloroquine treatment

García-Domene MC, Díez-Ajenjo MA, de Fez MD, Luque MJ

Clinical Optometry 2014, 6:59-70

Published Date: 30 September 2014

Visual performance and aberration associated with contact lens wear in patients with keratoconus: a pilot study

Abdu M, Mohidin N, Mohd-Ali B

Clinical Optometry 2014, 6:47-57

Published Date: 16 August 2014

Differences in daily disposable circle lens performance characteristics

Schafer JM, Reindel WT, Rah MJ, Chan O, Zhang L

Clinical Optometry 2014, 6:37-42

Published Date: 3 April 2014

Clinical agreement in pulmonary nontuberculous mycobacterial disease

Nolan PJ

Clinical Audit 2013, 5:95-98

Published Date: 7 November 2013

Audit of atypical hip fractures at the Royal Berkshire Hospital

Selvan S, Mills T, McNally J

Clinical Audit 2013, 5:91-93

Published Date: 20 September 2013

Pharmaceutical care – impact on quality of life in patients with type 2 diabetes: a review

Krass I, Dhippayom T

Clinical Audit 2013, 5:17-32

Published Date: 7 March 2013

Factors associated with patient selection for inpatient rehabilitation: an audit of decision-making in the rehabilitation assessment

Lim J, Churilov L, Smith P, Churilov I

Clinical Audit 2013, 5:1-9

Published Date: 20 January 2013